Olanzapine in the treatment of anorexia nervosa: An open label trial
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective: The primary goal of the study was to determine if olanzapine is effective in producing weight gain in patients with anorexia nervosa. Method: Twenty patients with anorexia nervosa (restricting or binge/purge subtype) without schizophrenia, schizoaffective disorder, or bipolar disorder enrolled in an open label study of olanzapine 10 mg. Patients attended weekly drug monitoring sessions and weekly group medication adherence sessions that provided psychoeducation. Results: Eighteen patients received the drug and 14 patients completed the 10‐week study. The four drop‐outs had gained a mean of 3.25 lb at their last visit. Of the 14 patients who completed the study, 10 gained an average of 8.75 lb and 3 of these patients attained their ideal body weight. The remaining four patients who completed the study lost a mean of 2.25 lb. Discussion: These findings are promising with clinically significant weight gain in an outpatient setting during a brief 10‐week period. © 2002 by Wiley Periodicals, Inc. Int J Eat Disord 32: 146–154, 2002.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in anorexia nervosa.
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.1073 · Cited by 974
Garfinkel, P. E., Lin, E., Goering, P., Spegg, C., Goldbloom, D., Kennedy, S., Kaplan, A. S., & Woodside, D. B. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.4.500 · Cited by 175
Cited by
Psychiatric Comorbidities of Female Inpatients With Eating Disorders
Blinder, B. J., Cumella, E. J., & Sanathara, V. A. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221254.77675.f5 · Cited by 423
Bissada, H., Tasca, G. A., Barber, A. M., & Bradwejn, J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07121900 · Cited by 268
Aigner, M., Treasure, J., Kaye, W., Kasper, S., & The WFSBP Task Force on Eating Disorders (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.602720 · Cited by 207
“There are some open or retrospective studies with olanzapine (Jensen and Mejlhede, 2000; La Via et al., 2000; Powers et al., 2002; Leggero et al., 2010; Malina et al., 2003; Boachie et al., 2003; Barbarich et al., 2004), with promising weight gain or psychopathological improvement in patients with…”
BackgroundOlanzapine therapy in anorexia nervosa: psychobiological effects
Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., Ramaciotti, C., Bondi, E., Mellado, C., Borriello, R., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328080ca31 · Cited by 156
“More recently, atypical antipsychotics, olanzapine (OLA), risperidone and amisulpride, in particular, in either single cases or in small patient groups, had been shown to improve eating habits, weight and some psychopathological aspects of AN (depression, anxiety, obsessivity–compulsivity, psychoticism) (Hansen, 1999;…”
BackgroundResultInfluentialSecond-Generation Antipsychotic Medications in Children and Adolescents
Cheng-Shannon, J., McGough, J. J., Pataki, C., & McCracken, J. T. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.372 · Cited by 152
Metadata
- Authors
- Powers, P. S., Santana, C. A., & Bannon, Y. S.
- Venue
- International Journal of Eating Disorders
- Publisher
- Wiley
- Published
- 2002-07-18
- Volume
- 32
- Issue
- 2
- Pages
- 146-154
- ISSN
- 0276-3478 (ISSN-L)
- 1098-108X
- OpenAlex
- W2073588187
- Cited by
- 150
- References
- 2
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.